As of 2026-07-13, the Relative Valuation of Edwards Lifesciences Corp (EW) is 61.35 USD. This relative valuation is based on P/E multiples. With the latest stock price at 92.21 USD, the upside of Edwards Lifesciences Corp based on Relative Valuation is -33.5%.
The range of the Relative Valuation is 56.01 - 71.84 USD.
| Range | Selected | |
| Trailing P/E multiples | 29.4x - 33.5x | 31.2x |
| Forward P/E multiples | 24.4x - 30.9x | 27.2x |
| Fair Price | 56.01 - 71.84 | 61.35 |
| Upside | -39.3% - -22.1% | -33.5% |
| Date | P/E |
| 2026-07-10 | 48.44 |
| 2026-07-09 | 47.97 |
| 2026-07-08 | 49.19 |
| 2026-07-07 | 49.81 |
| 2026-07-06 | 50.00 |
| 2026-07-02 | 49.57 |
| 2026-07-01 | 48.32 |
| 2026-06-30 | 47.52 |
| 2026-06-29 | 47.89 |
| 2026-06-26 | 47.68 |
| 2026-06-25 | 47.13 |
| 2026-06-24 | 47.10 |
| 2026-06-23 | 45.67 |
| 2026-06-22 | 45.11 |
| 2026-06-18 | 45.89 |
| 2026-06-17 | 45.53 |
| 2026-06-16 | 46.53 |
| 2026-06-15 | 45.32 |
| 2026-06-12 | 44.71 |
| 2026-06-11 | 45.05 |
| 2026-06-10 | 45.16 |
| 2026-06-09 | 45.98 |
| 2026-06-08 | 45.09 |
| 2026-06-05 | 45.15 |
| 2026-06-04 | 45.93 |
| 2026-06-03 | 45.17 |
| 2026-06-02 | 46.05 |
| 2026-06-01 | 46.31 |
| 2026-05-29 | 45.42 |
| 2026-05-28 | 45.15 |
| 2026-05-27 | 45.44 |
| 2026-05-26 | 45.98 |
| 2026-05-22 | 45.06 |
| 2026-05-21 | 43.70 |
| 2026-05-20 | 43.58 |
| 2026-05-19 | 43.16 |
| 2026-05-18 | 43.28 |
| 2026-05-15 | 42.75 |
| 2026-05-14 | 42.73 |
| 2026-05-13 | 42.75 |
| 2026-05-12 | 41.88 |
| 2026-05-11 | 40.54 |
| 2026-05-08 | 42.00 |
| 2026-05-07 | 43.47 |
| 2026-05-06 | 43.70 |
| 2026-05-05 | 43.55 |
| 2026-05-04 | 43.77 |
| 2026-05-01 | 44.11 |
| 2026-04-30 | 43.86 |
| 2026-04-29 | 42.66 |